November 28, 2024 - 06:05

Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
May 25, 2026 - 23:35
Pope calls for AI regulation, using technology for common good rather than profitPope Leo XIV issued a powerful call for global regulation of artificial intelligence on Monday, urging developers and governments to prioritize the common good over corporate profits. In a...
May 25, 2026 - 07:17
ANT Systems Launches Industrial-Scale Production of Drought Technology Used on Five ContinentsISTANBUL, Türkiye -- Agricultural nano-technology company ANT Systems has announced the start of industrial-scale production of NANOTERN, a biodegradable water-retention material made from...
May 24, 2026 - 23:42
POET Technologies: Great Technology, Terrible InvestmentPOET Technologies, once a high-flying name in the photonics space, has been handed a Sell rating by analysts who see little near-term payoff for investors. The core issue is a stark mismatch...
May 24, 2026 - 04:15
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the BunchThe first quarter earnings season has now drawn to a close for the healthcare technology for providers sector, and the results paint a clear picture of which companies are thriving and which are...